513
Views
5
CrossRef citations to date
0
Altmetric
Mini-review

Designing phase II clinical trials in Friedreich ataxia

&
Pages 415-423 | Received 04 Aug 2021, Accepted 19 Oct 2021, Published online: 22 Dec 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Sylvia Boesch & Elisabetta Indelicato. (2023) Experimental drugs for Friedrich’s ataxia: progress and setbacks in clinical trials. Expert Opinion on Investigational Drugs 32:11, pages 967-969.
Read now

Articles from other publishers (4)

Mario Manto. 2023. Essentials of Cerebellum and Cerebellar Disorders. Essentials of Cerebellum and Cerebellar Disorders 617 620 .
Simge Kelekçi, Abdullah Burak Yıldız, Kenan Sevinç, Deniz Uğurlu Çimen & Tamer Önder. (2022) Perspectives on current models of Friedreich’s ataxia. Frontiers in Cell and Developmental Biology 10.
Crossref
Wing-Hang Tong, Hayden Ollivierre, Audrey Noguchi, Manik C. Ghosh, Danielle A. Springer & Tracey A. Rouault. (2022) Hyperactivation of mTOR and AKT in a cardiac hypertrophy animal model of Friedreich ataxia. Heliyon 8:8, pages e10371.
Crossref
Alessandra Rufini, Florence Malisan, Ivano Condò & Roberto Testi. (2022) Drug Repositioning in Friedreich Ataxia. Frontiers in Neuroscience 16.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.